Cited by 2,317Cancer-related Molecular PathwaysGenomics and Chromatin DynamicsSignaling Pathways in Disease

The regulation of E2F by pRB-family proteins.

Open access
Dyson, Nicholas·1998·Genes & Development

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.12.15.2245

Cites

205 of 205 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These proteins share a common bipartite pocket region comprising a LXCXE motif, which allows them to interact directly with other proteins.

    “These proteins share a common bipartite pocket region comprising a LXCXE motif, which allows them to interact directly with other proteins (Dyson, 1998).”
  • Senescence signaling typically acts by decreasing cyclin-CDK activity or increasing CDK inhibitor levels.

    “Due to the critical regulatory role of these cell cycle factors, senescence signaling typically acts by decreasing cyclin–CDK activity or increasing CDK inhibitor levels.”

    From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [33]

  • Rb pathway mutations promote tumour development by deregulating E2F transcription factors and causing uncontrolled cell cycle progression.

    “These mutations promote tumour development by deregulating the E2F family of transcription factors leading to uncontrolled cell cycle progression 3 .”
  • CDK4/6 phosphorylates RB to prime it for inactivation by other CDKs later in G1, releasing E2F transcription factors to induce S-phase genes.

    “Together, these results implied that the role of CDK4/6 was to phosphorylate RB, priming it for inactivation by other CDKs later in G1, and releasing E2F transcription factors from RB constraint to allow their coordinate induction of a suite of genes whose activities are jointly required for initiation of S phase [reviewed in detail in (16) (29-31)].”

    From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [29]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Neufeld, T.P., A.F.A. de la Cruz, L.A. Johnston, and B.A. Edgar. 1998. Coordination of cell growth and division by Dro- sophila E2F. Cell (in press).
  2. Schwarz, J.K., C.H. Bassing, I. Kovesdi, M.B. Datto, M. Blazing, S. George, X. Wang, and J.R. Nevins. 1995. Expression of the E2F1 transcription factor overcomes TGF-␤ mediated growth suppression. Proc. Natl. Acad. Sci. 92: 483-487.

Cited by

Sorted by citations

Authors
Dyson, N.
Affiliations
Massachusetts General Hospital (US)
Corresponding author
Dyson, Nicholas
Venue
Genes & Development
Published
1998-08-01
Volume
12
Issue
15
Pages
2245-2262
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2034277114
Cited by
2,317
References
205
Citations by year
2026: 14 · 2025: 27 · 2024: 27 · 2023: 35 · 2022: 41 · 2021: 63 · 2020: 49 · 2019: 36 · 2018: 39 · 2017: 48 · 2016: 43 · 2015: 49 · 2014: 54 · 2013: 66 · 2012: 78
Type
posted content
Language
en
Open access
Locations
  • Genes & Development (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (CA64402, R01CA064402)
  • National Institute of General Medical Sciences (GM-53203, R01GM053203)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
E2F transcription factors, retinoblastoma protein, cell cycle regulation, transcriptional repression, cell cycle checkpoints
MeSH terms
Animals, Binding Sites, Carrier Proteins, DNA-Binding Proteins, Humans, Oncogenes, Phosphorylation, Repressor Proteins, Transcription Factors, Transcriptional Activation, Genes, Tumor Suppressor, Retinoblastoma Protein, S Phase, Apoptosis, Cell Cycle Proteins, Transcription Factor DP1, E2F Transcription Factors, Retinoblastoma-Binding Protein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review